MSMohammad Sharifi Sarasyabi

Mohammad Sharifi Sarasyabi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mohammad Sharifi Sarasyabi has a total of 43 co-authors. Here are the top co-authors by number of shared publications:

  • Parnian Shobeiri

    School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

    2 shared publications
  • Amirhossein Habibzadeh

    Department of Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

    1 shared publication
  • Ankit Parakh

    Pediatric Respiratory Division BLK Max Hospital New Delhi India

    1 shared publication
  • Asal Khalili Dehkordi

    Department of Cardiovascular Surgery, Research Center for Advanced Technologies in Cardiovascular Medicine, Cardiovascular Research Institute, Tehran University of Medical Sciences, Tehran, Iran

    1 shared publication
  • Babak Mansourian

    Department of General Surgery, Shahid Madani Clinical Research Development Unit, Student Research Committee, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran

    1 shared publication
  • Farshid Bozorgnia

    Rheumatology, University of California Irvine Medical Center, Orange, USA

    1 shared publication

Latest Publications

  • Open Access

    Burden of gallbladder and biliary tract cancer (GBTC) in the middle east and North Africa (MENA) from 1990 to 2021: from the global burden of disease (GBD)

    by Babak Mansourian, Tarannom Sadegh, Amirhossein Habibzadeh, Sogol Hajifathali, Asal Khalili Dehkordi, Mahshid Jamshidi, Mohammad Sharifi Sarasyabi, Kasra Hatampour, Khashayar Danandeh

    Introduction: Gallbladder and biliary tract cancer (GBTC) is a rare but aggressive malignancy with poor survival outcomes, mainly due to late-stage diagnosis and limited treatment options. Despite prominent global disparities in incidence and outcomes, comprehensive data on the GBTC burden in the Middle East and North Africa (MENA) region remain scarce. Materials and methods: We used Global Burden of Disease (GBD) 2021 data. We retrieved incidence, deaths, and DALYs, including crude and age-standardized rates per 100 000, with 95% uncertainty intervals for 21 MENA countries, the MENA region, and globally, stratified by year (1990–2021), sex, and age group. Results: In the MENA region, the age-standardized incidence rate (ASIR) remained at 1.4 per 100 000 in both 1990 and 2021 (−0.2% change), while globally it declined from 2.89 to 2.56 (−11.5%; 95% UI: −21.9 to −3.4). The age-standardized death rate (ASDR) decreased from 1.50 to 1.37 (−9.0%) in MENA versus 2.69 to 2.04 (−24.1%; 95% UI: −33.2 to −16.9) globally. The age-standardized DALY rate fell from 34.26 to 29.82 (−13.0%) in MENA and from 58.58 to 43.20 (−26.2%; 95% UI: −35.5 to −18.4) globally. Across years, females had higher age-standardized rates than males, rates increased with age, and the peak DALY rate shifted from 80–84 (1990) to 85–89 (2021). Conclusions: While the burden of GBTC has decreased in the MENA region and has consistently remained lower than the global average, there is considerable heterogeneity across countries in the region that warrants the attention of policymakers, particularly in countries with a higher burden of GBTC, such as Libya and the United Arab Emirates, and in countries with an increasing burden, such as Iran.

  • Allergic fungal rhinosinusitis and its fungal species in Eastern Mediterranean: A systematic review

    by Mehraneh Movahedi Aliabadi, Mohammad Sharifi Sarasyabi, Reyhaneh Asoudeh, Keihan Mostafavi, Maryam Emadzadeh, Hossein Zarrinfar

  • Open Access

    Blood levels of brain-derived neurotrophic factor (BDNF) in psoriasis: a systematic review and meta-analysis

    by Mohammad Sharifi Sarasyabi, Niloofar Seighali, Maryam Abdolmaleki, Parnian Shobeiri, Mohammad R. Movahed, Farshid Bozorgnia, Saba Maleki

  • Open Access

    A systematic review, meta-analysis, and network analysis of diagnostic microRNAs in glaucoma

    by Masoud Rezaei, Mahsa Faramarzpour, Parnian Shobeiri, Homa Seyedmirzaei, Mohammad Sharifi Sarasyabi, Shahriar Dabiri

    Glaucoma is a chronic neurodegenerative process of the optic nerve that is the leading cause of blindness worldwide, and early diagnosis of the disease could greatly affect patients’ prognoses. The pathophysiology of glaucoma is complicated by a combination of genetic and epigenetic factors. Deciphering the early diagnostic biomarkers in glaucoma could attenuate the disease's global burden and help us understand the exact mechanisms involved in glaucoma. The microRNAs are members of a larger family of non-coding RNAs that play an essential role in the epigenetic basis of glaucoma. A systematic study and meta-analysis of diagnostic microRNAs in glaucoma, jointly with network analysis of target genes, were carried out on published papers assessing differentially expressed microRNAs in human subjects. In total, 321 articles were found, and, after screening, six studies were eligible for further analysis. 52 differentially expressed microRNAs were found, of which 28 and 24 were up-regulated and down-regulated, respectively. Only 12 microRNAs were qualified for meta-analysis, with overall sensitivity and specificity of 80% and 74%, respectively. Then, using network analysis, it became apparent that the VEGF-A, AKT1, CXCL12, and HRAS genes were the most important targets for the microRNAs. Perturbations in WNT signaling, protein transport, and extracellular matrix organization pathways were discovered to be important in the etiology of glaucoma using the community detection approach. This study tries to uncover the promising microRNAs and their target genes that govern the epigenetics of glaucoma.


  • The characteristics of foreign bodies aspirated by children across different continents: A comparative review

    by Seyedeh Yasamin Parvar, Mohammad Sharifi Sarasyabi, Mohammad Ashkan Moslehi, Kostas N. Priftis, Renato Cutrera, Meng Chen, Zhong Lili, Hari K. Gonuguntla, Tinku Joseph, Mohsen Alajmi, et al.

    Background: Foreign body aspiration (FBA) is a common issue in pediatric emergencies, with regional variations. Various cultures and foods, parents' and physicians' inadequate experience, and lack of bronchoscopy equipment are some attributable factors in the regional variation of FBA.Aim: To more accurately represent the demographic characteristics of aspirated foreign bodies (FBs) across various continents, this review attempted to provide organized information based on the reviewed articles.Methodology: A search was conducted in PubMed/PubMed Central, EMBASE, and google scholar. From the 36 included articles, information on age, gender, bronchoscopy type, type of FB, location, history of choking, and time elapsed between aspiration and admission were extracted.Results: A total of 14,469 cases were evaluated. According to the findings, children under two accounted for more than 75% of FBAs. Nuts and seeds were the most common FBs in most countries, whereas plastic and metal objects had higher rates in Brazil, and calcified objects were more prevalent in Thailand. The right bronchus was the most frequent location, and rigid bronchoscopy was the most often utilized type of bronchoscope. In addition, a significant percentage of patients were referred to the emergency rooms in the first 12−24 h following the aspiration incident. Moreover, Asian patients reported more choking history, and Europeans had fewer witnesses of FBA.Conclusions: There is a lack of standardized reporting systems and organized guidelines in pediatric FBA. To select the ideal time for endoscopies and create educational programs, a collaboration between experienced researchers, pediatric pulmonologists, radiologists, and otolaryngologists is required.


  • The therapeutic role of lasers in primary localized cutaneous amyloidosis: a systematic review

    by Najmeh Ahramiyanpour, Zahra Akbari, Mohammad Sharifi Sarasyabi, Mahin Aflatoonian, Nasrin Saki, Mohammad Shafie’eI

    With the investigation of the efficacy of laser therapy in primary localized amyloidosis(PLCA) only recently starting to materialize, we aimed to review the currently available studies of laser therapy in the management of the disease. We searched PubMed, Scopus, Embase, Web of Science, Cochrane, and ProQuest online databases with a specified search strategy, assessed the quality of each study, and then extracted the eligible data. Five RCTs(randomized controlled trials), one non-randomized controlled trial, three case series, and nine case reports(18 in total) were included. Overall, carbon dioxide (CO2), neodymium-doped:yttrium aluminum garnet (Nd:YAG), pulsed dye (PDL), Er (Erbium):YAG, and yttrium/erbium fiber were the studied lasers. One hundred fifty-five cases in total underwent laser therapy, with CO2 being the most frequent laser. Almost all studies demonstrated significantly desirable outcomes, while only mild and transient side effects were noted. Even though the studies’ results were significant, we noticed that implementing a consistent methodology and a standardized objective assessment method was missing. Therefore, we recommend that future studies be conducted with less heterogeneous data for a more definite conclusion.